Cryo Cell International (CCEL) Operating Margin (2016 - 2025)
Cryo Cell International (CCEL) has disclosed Operating Margin for 16 consecutive years, with 62.98% as the latest value for Q4 2025.
- On a quarterly basis, Operating Margin fell 2543.0% to 62.98% in Q4 2025 year-over-year; TTM through Nov 2025 was 1.55%, a 340.0% decrease, with the full-year FY2025 number at 1.55%, down 340.0% from a year prior.
- Operating Margin was 62.98% for Q4 2025 at Cryo Cell International, down from 24.29% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 27.69% in Q2 2021 to a low of 84.79% in Q4 2023.
- A 5-year average of 1.61% and a median of 15.2% in 2022 define the central range for Operating Margin.
- Peak YoY movement for Operating Margin: tumbled -4715bps in 2023, then skyrocketed 4723bps in 2024.
- Cryo Cell International's Operating Margin stood at 11.05% in 2021, then plummeted by -241bps to 37.64% in 2022, then plummeted by -125bps to 84.79% in 2023, then skyrocketed by 56bps to 37.56% in 2024, then tumbled by -68bps to 62.98% in 2025.
- Per Business Quant, the three most recent readings for CCEL's Operating Margin are 62.98% (Q4 2025), 24.29% (Q3 2025), and 18.83% (Q2 2025).